By REBECCA DYER Researchers have dis­covered how a cell surface protein called Aplp1 can play a role in spreading material respon­sible for Parkinson’s disease from cell-to-cell in the brain. Promisingly, an FDA-ap­proved cancer drug that targets another protein called Lag3 – which interacts with Aplp1 – blocks the spread in mice, sug­gesting a potential therapy…